LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Penumbra Inc

Geschlossen

BrancheGesundheitswesen

297.02 2.91

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

295.12

Max

299.41

Schlüsselkennzahlen

By Trading Economics

Einkommen

5.5M

39M

Verkäufe

8.6M

324M

KGV

Branchendurchschnitt

276.636

54.379

EPS

0.83

Gewinnspanne

12.101

Angestellte

4,500

EBITDA

131K

49M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+6.28% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

734M

11B

Vorheriger Eröffnungskurs

294.11

Vorheriger Schlusskurs

297.02

Nachrichtenstimmung

By Acuity

50%

50%

170 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Penumbra Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Mai 2025, 23:48 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11. Mai 2025, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11. Mai 2025, 23:45 UTC

Market Talk

Oil Rises Amid Improved Market Mood -- Market Talk

11. Mai 2025, 23:38 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Aristocrat Has Significant Firepower for M&A -- Market Talk

11. Mai 2025, 23:36 UTC

Market Talk

Global Markets Uncertain About US-China Trade News -- Market Talk

11. Mai 2025, 23:35 UTC

Market Talk

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11. Mai 2025, 23:33 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11. Mai 2025, 23:32 UTC

Top News

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11. Mai 2025, 22:44 UTC

Market Talk

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11. Mai 2025, 22:33 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11. Mai 2025, 20:19 UTC

Top News

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11. Mai 2025, 16:00 UTC

Top News

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11. Mai 2025, 11:00 UTC

Top News

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11. Mai 2025, 08:00 UTC

Top News

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11. Mai 2025, 01:00 UTC

Top News

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11. Mai 2025, 01:00 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10. Mai 2025, 21:54 UTC

Top News

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10. Mai 2025, 17:12 UTC

Top News

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10. Mai 2025, 15:41 UTC

Top News

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10. Mai 2025, 12:00 UTC

Top News

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10. Mai 2025, 09:30 UTC

Top News

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10. Mai 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

10. Mai 2025, 03:52 UTC

Top News

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9. Mai 2025, 23:51 UTC

Akquisitionen, Fusionen, Übernahmen

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9. Mai 2025, 22:06 UTC

Market Talk

Arm Holdings Remains a Strong Growth Story -- Market Talk

9. Mai 2025, 21:37 UTC

Top News

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9. Mai 2025, 21:10 UTC

Top News

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9. Mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9. Mai 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

9. Mai 2025, 20:42 UTC

Top News

Stocks Get a Break From Trade Chaos -- WSJ

Peer-Vergleich

Kursveränderung

Penumbra Inc Prognose

Kursziel

By TipRanks

6.28% Vorteil

12-Monats-Prognose

Durchschnitt 316 USD  6.28%

Hoch 340 USD

Tief 260 USD

Basierend auf 16 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Penumbra Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

16 ratings

13

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

288.28 / 292.9394Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

170 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.